| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $723,654,798 ) (Continued on the next page) |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | UG3CA305777 | Implementation science to scale and sustain tobacco treatment leveraging point of care paradigm and health information technology | 000 | 1 | NIH | 9/5/2025 | $1,594,797 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R56HD096737 | Quantitative and computational characterization of oxytocin receptor function | 000 | 6 | NIH | 8/29/2025 | $999,593 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21EY038987 | Scaling Strategies to Assess Pathogenicity of Variants of Uncertain Significance | 000 | 1 | NIH | 9/11/2025 | $427,625 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K01MD020519 | A Precision Medicine Approach to Fetal Growth Restriction Among Black Women | 000 | 1 | NIH | 9/5/2025 | $134,404 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01HS029872 | Combatting Community-Associated Antimicrobial Resistant Organisms Combat CA-ARO Study | 000 | 2 | AHRQ | 2/10/2025 | $249,999 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R00AG078493 | Investigating the role of cGAS signaling and microglial senscence in tauopathy | 001 | 3 | NIH | 9/24/2025 | $0 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG031867 | Protein aggregation in inclusion body and myofibrillar myopathies | 002 | 17 | NIH | 6/10/2025 | $52,034 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AG031867 | Protein aggregation in inclusion body and myofibrillar myopathies | 001 | 17 | NIH | 3/19/2025 | $585,381 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01MH143055 | SCH: Mechanism-based dose titration for modifying brain electrophysiology during antidepressant therapy | 000 | 1 | NIH | 8/4/2025 | $284,333 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R00AG078493 | Investigating the role of cGAS signaling and microglial senscence in tauopathy | 000 | 3 | NIH | 8/6/2025 | $244,020 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21HD117239 | Consequences of Postpartum Exogenous Oxytocin on Maternal-Neonatal Oxytocinergic Signaling and Behavior | 000 | 1 | NIH | 8/6/2025 | $427,625 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM160196 | Regulation of the mitotic DNA damage response | 000 | 1 | NIH | 8/6/2025 | $1,943,750 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01EB036573 | Sensing Collimator Technology for Ultrasensitive SPECT Imaging of Targeted Radiopharmaceutical Therapies | 000 | 1 | NIH | 7/29/2025 | $598,134 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AI191507 | Advancing lymphatic filariasis elimination with parasite genomic epidemiology | 000 | 1 | NIH | 7/25/2025 | $777,360 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01EB038720 | SCH: Wearable Bi-modal Imaging System with Multi-scale AI for Uterine Contraction Mapping in Obstetric Care | 001 | 1 | NIH | 9/18/2025 | $150,000 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01EB038720 | SCH: Wearable Bi-modal Imaging System with Multi-scale AI for Uterine Contraction Mapping in Obstetric Care | 001 | 1 | NIH | 9/18/2025 | -$150,000 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R03AI194212 | Molecular Basis of Receptor Interactions for Venezuelan Equine Encephalitis | 000 | 1 | NIH | 7/23/2025 | $155,454 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS140701 | Cortical dystonia of prematurity | 000 | 1 | NIH | 7/30/2025 | $596,989 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01EB038720 | SCH: Wearable Bi-modal Imaging System with Multi-scale AI for Uterine Contraction Mapping in Obstetric Care | 000 | 1 | NIH | 7/28/2025 | $237,078 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R03AG088746 | Circadian Clock Disruption as a Novel Mechanism to Influence Osteoarthritis Risk in Aging Populations | 000 | 1 | NIH | 7/23/2025 | $155,500 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21AI183079 | Exploiting the bacteriophage arsenal to discover novel classes of anti-biofilm agents | 000 | 1 | NIH | 7/23/2025 | $427,625 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21EB037898 | Development of a Novel Biomarker and PET Radiotracer for Specific Imaging of Microglial Responses | 001 | 1 | NIH | 8/27/2025 | $0 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21EB037898 | Development of a Novel Biomarker and PET Radiotracer for Specific Imaging of Microglial Responses | 000 | 1 | NIH | 7/30/2025 | $618,670 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K23HD114877 | Refractive surgery for ASD | 000 | 1 | NIH | 7/29/2025 | $168,053 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01HS029872 | Combatting Community-Associated Antimicrobial Resistant Organisms Combat CA-ARO Study | 001 | 2 | AHRQ | 7/7/2025 | $249,999 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS144659 | Exploring activity-dependent regulation of intra and intercellular mitochondrial transport in astrocytes | 000 | 1 | NIH | 7/30/2025 | $488,232 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | DP2GM164659 | Time-lapse epigenome profiling in support of next generation cellular reprogramming | 000 | 1 | NIH | 7/24/2025 | $1,399,500 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R21AI188191 | Culturomic and metagenomic methods optimization to detect multi-strain C. difficile colonization and infection | 000 | 1 | NIH | 7/23/2025 | $233,250 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA254060 | Leader cell development and function in Breast Tumor Collective Migration | 001 | 4 | NIH | 5/22/2025 | $50,375 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA254060 | Leader cell development and function in Breast Tumor Collective Migration | 000 | 4 | NIH | 3/19/2025 | $453,386 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DK119147 | Intestinally restricted LXR agonism in ameliorating liver failure in short gut syndrome | 002 | 7 | NIH | 7/10/2025 | $590,587 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K23HL173684 | Improving Maternal Cardiovascular Outcomes through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria | 000 | 2 | NIH | 2/25/2025 | $186,259 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R35GM160185 | Molecular mechanisms of compound microtubule structure and function | 000 | 1 | NIH | 7/22/2025 | $427,625 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K23HL171940 | Implementation of SMART therapy for asthma patients in low-resource community health centers | 000 | 2 | NIH | 2/25/2025 | $208,436 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01MH104494 | Neuronal Mechanisms of Good-Based Economic Decisions | 001 | 10 | NIH | 9/18/2025 | $66,199 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01DA062509 | Mesolimbic adaptations underlying altered reward sensitivity in neuropathic pain | 000 | 1 | NIH | 8/7/2025 | $668,131 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01AI129545 | Natural Killer Cell Tolerance to Self | 000 | 9 | NIH | 3/19/2025 | $577,804 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01MH104494 | Neuronal Mechanisms of Good-Based Economic Decisions | 000 | 10 | NIH | 3/19/2025 | $375,133 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K08DK132496 | Neoglycosylation Epitopes in Metaplasia and Cancer | 000 | 4 | NIH | 2/18/2025 | $165,062 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K12HD119716 | WashU-WRHR; Gateway to Improving Women's Reproductive Health | 000 | 1 | NIH | 7/28/2025 | $340,200 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01CA237263 | DNA replication stress in cancer | 002 | 8 | NIH | 3/10/2025 | $379,502 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS128080 | Mechanisms of migraine chronification and reversal | 000 | 3 | NIH | 3/14/2025 | $428,510 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K08AR079593 | Identification of Pathogenic T cells in Axial Spondyloarthritis | 001 | 4 | NIH | 7/10/2025 | $154,776 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | K08AR079593 | Identification of Pathogenic T cells in Axial Spondyloarthritis | 000 | 3 | NIH | 2/27/2025 | $649 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R00AG073452 | Examining the impact of sex and hormones on the progression of autosomal dominant Alzheimer's disease | 000 | 3 | NIH | 8/7/2025 | $243,684 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS103988 | PET Sphingosine-1-Phosphate Receptor 1 (S1P1) radiotracer for inflammation response in multiple sclerosis | 002 | 8 | NIH | 5/29/2025 | $625,133 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R01NS121612 | Connecting Alzheimer's Disease to Traumatic Synaptic Neurodegeneration | 000 | 4 | NIH | 3/14/2025 | $532,957 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | R00MH129983 | Gene regulatory networks influencing neuron-microglia interactions in fetal brain development. | 000 | 4 | NIH | 3/7/2025 | $204,282 |
| | 2025 | 2025 | WASHINGTON UNIVERSITY, THE | 1 BROOKINGS DR | SAINT LOUIS | MO | 63130-4862 | SAINT LOUIS | USA | U01DE034565 | Validation of a clinically accessible prognostic biomarker for oropharynx cancer using molecular and spatial data | 004 | 1 | NIH | 8/15/2025 | $32,872 |
|
